Allelic Diversity and Geographical Distribution of the Gene Encoding Plasmodium falciparum Merozoite Surface Protein-3 in Thailand
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Merozoite surface proteins (MSPs) of malaria parasites play critical roles during the erythrocyte invasion and so are potential candidates for malaria vaccine development. However, because MSPs are often under strong immune selection, they can exhibit extensive genetic diversity. The gene encoding the merozoite surface protein-3 (MSP-3) of Plasmodium falciparum displays 2 allelic types, K1 and 3D7. In Thailand, the allelic frequency of the P. falciparum msp-3 gene was evaluated in a single P. falciparum population in Tak at the Thailand and Myanmar border. However, no study has yet looked at the extent of genetic diversity of the msp-3 gene in P. falciparum populations in other localities. Here, we genotyped the msp-3 alleles of 63 P. falciparum samples collected from 5 geographical populations along the borders of Thailand with 3 neighboring countries (Myanmar, Laos, and Cambodia). Our study indicated that the K1 and 3D7 alleles coexisted, but at different proportions in different Thai P. falciparum populations. K1 was more prevalent in populations at the Thailand-Myanmar and Thailand-Cambodia borders, whilst 3D7 was more prevalent at the Thailand-Laos border. Global analysis of the msp-3 allele frequencies revealed that proportions of K1 and 3D7 alleles of msp-3 also varied in different continents, suggesting the divergence of malaria parasite populations. In conclusion, the variation in the msp-3 allelic patterns of P. falciparum in Thailand provides fundamental knowledge for inferring the P. falciparum population structure and for the best design of msp-3 based malaria vaccines.
Abstract
Merozoite surface proteins (MSPs) of malaria parasites play critical roles during the erythrocyte invasion and so are potential candidates for malaria vaccine development. However, because MSPs are often under strong immune selection, they can exhibit extensive genetic diversity. The gene encoding the merozoite surface protein-3 (MSP-3) of Plasmodium falciparum displays 2 allelic types, K1 and 3D7. In Thailand, the allelic frequency of the P. falciparum msp-3 gene was evaluated in a single P. falciparum population in Tak at the Thailand and Myanmar border. However, no study has yet looked at the extent of genetic diversity of the msp-3 gene in P. falciparum populations in other localities. Here, we genotyped the msp-3 alleles of 63 P. falciparum samples collected from 5 geographical populations along the borders of Thailand with 3 neighboring countries (Myanmar, Laos, and Cambodia). Our study indicated that the K1 and 3D7 alleles coexisted, but at different proportions in different Thai P. falciparum populations. K1 was more prevalent in populations at the Thailand-Myanmar and Thailand-Cambodia borders, whilst 3D7 was more prevalent at the Thailand-Laos border. Global analysis of the msp-3 allele frequencies revealed that proportions of K1 and 3D7 alleles of msp-3 also varied in different continents, suggesting the divergence of malaria parasite populations. In conclusion, the variation in the msp-3 allelic patterns of P. falciparum in Thailand provides fundamental knowledge for inferring the P. falciparum population structure and for the best design of msp-3 based malaria vaccines.
참고문헌 (39)
- Miller LH, "The pathogenic basis of malaria", Nature, 415, pp.673~679 (2002)
- Breman JG, "The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden", Am J Trop Med Hyg, 64, pp.1~11 (2001)
- Cui L, "Malaria in the Greater Mekong Subregion: heterogeneity and complexity", Acta Trop, 121, pp.227~239 (2012)
- Noedl H, "Evidence of artemisinin-resistant malaria in western Cambodia", N Engl J Med, 359, pp.2619~2620 (2008)
- Phyo AP, "Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study", Lancet, 379, pp.1960~1966 (2012)
- Fairhurst RM, "Artemisinin-resistant malaria: research challenges, opportunities, and public health implications", Am J Trop Med Hyg, 87, pp.231~241 (2012)
- Ellis RD, "Blood stage vaccines for Plasmodium falciparum: current status and the way forward", Hum Vaccin, 6, pp.627~634 (2010)
- Miller LH, "Malaria biology and disease pathogenesis: insights for new treatments", Nat Med, 19, pp.156~167 (2013)
- Anders RE, "Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum", Hum Vaccin, 6, pp.39~53 (2010)
- McColl DJ, "Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites", Mol Biochem Parasitol, 68, pp.53~67 (1994)
- Oeuvray C, "A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies", Mem Inst Oswaldo Cruz, 89(Suppl 2), pp.77~80 (1994)
- Oeuvray C, "Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes", Blood, 84, pp.1594~1602 (1994)
- Hisaeda H, "Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys", J Infect Dis, 185, pp.657~664 (2002)
- Carvalho LJ, "Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels", Scand J Immunol, 59, pp.363~372 (2004)
- Soe S, "Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein", Infect Immun, 72, pp.247~252 (2004)
- Polley SD, "Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection", J Infect Dis, 195, pp.279~287 (2007)
- Osier FH, "Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3", Parasite Immunol, 29, pp.387~394 (2007)
- Audran R, "Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen", Infect Immun, 73, pp.8017~8026 (2005)
- Sirima SB, "Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa", Vaccine, 25, pp.2723~2732 (2007)
- Lusingu JP, "Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months", Malar J, 8, pp.163~ (2009)
- Sirima SB, "Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children", PLoS One, 4, pp.e7549~ (2009)
- McColl DJ, "Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3)", Mol Biochem Parasitol, 90, pp.21~31 (1997)
- Huber W, "Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3", Mol Biochem Parasitol, 87, pp.231~234 (1997)
- Jordan SJ, "Genetic diversity of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-3 in a hypoendemic transmission environment", Am J Trop Med Hyg, 80, pp.479~486 (2009)
- Ebrahimzadeh A, "Allelic forms of merozoite surface protein-3 in Plasmodium falciparum isolates from Southeast of Iran", Jundishapur J Microbiol, 7, pp.e9829~ (2014)
- Soulama I, "Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen-1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from western and central Africa", Am J Trop Med Hyg, 84, pp.276~284 (2011)
- Simpalipan P, "Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1", Malar J, 13, pp.54~ (2014)
- Pumpaibool T, "Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country", Malar J, 8, pp.155~ (2009)
- Gardner MJ, "Genome sequence of the human malaria parasite Plasmodium falciparum", Nature, 419, pp.498~511 (2002)
- Excoffier L, "Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows", Mol Ecol Resour, 10, pp.564~567 (2010)
- Cui L, "Challenges and prospects for malaria elimination in the Greater Mekong Subregion", Acta Trop, 121, pp.240~245 (2012)
- Pattaradilokrat S, "Malaria Parasites: Comparative Genomics, Evolution and Molecular Biology", pp.59~90 (2013), Caister Academic Press
- Jiraporn Kuesap, "Evolution of genetic polymorphisms of Plasmodium falciparum merozoite surface protein (PfMSP) in Thailand", The Korean Journal of Parasitology, 52(1), pp.105~109 (2014), 대한기생충학ㆍ열대의학회[DOI]
- Rungsihirunrat K, "Genotyping of polymorphic marker (MSP3alpha and MSP3beta) genes of Plasmodium vivax field isolates from malaria endemic of Thailand", Trop Med Int Health, 16, pp.794~801 (2011)
- James S, "Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1", ChemBiochem, 7, pp.1943~1950 (2006)
- Pizarro JC, "Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate", J Mol Biol, 328, pp.1091~1103 (2003)
- Kamolratanakul P, "Epidemiological studies of malaria at Pong Nam Ron, eastern Thailand", Southeast Asian J Trop Med Public Health, 25, pp.425~429 (1994)
- Wangroongsarb P, "Characteristics and malaria prevalence of migrant populations in malaria-endemic areas along the Thai-Cambodian border", Southeast Asian J Trop Med Public Health, 43, pp.261~269 (2012)
- Bang G, "Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs", PLoS One, 6, pp.e28165~ (2011)